<ul class="ProvisionList"><li><p class="Subsection amending"><strong><a class="sectionLabel" id="s-204"><span class="sectionLabel">204</span></a></strong> <a class="lawLabel" id="s-204ss-(1)ID0EBBA"><span class="lawlabel">(1)</span></a> Item 1 of Schedule II to the Act is repealed.</p></li><li><p class="Subsection amending"><a class="lawLabel" id="s-204ss-(2)ID0ECAA"><span class="lawlabel">(2)</span></a> The portion of item 2 of Schedule II to the Act before subitem (1) is replaced by the following:</p><section><div class="AmendedText"><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><a class="lawLabel" id="s-204ss-(2)AmendedTextListItem2ID0EBAAAAA"><span class="lawlabel">2</span></a> </div><div class="listItemText2">Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of any substance that is identical to any phytocannabinoid and with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts — including those that fall within the following core chemical structure classes:</div></div></li></ul></figure></div></section></li></ul>
